Immunoassay News and Research

RSS
NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

COVID-19 test kits offered by Carolina Liquid Chemistries granted FDA emergency use authorization

COVID-19 test kits offered by Carolina Liquid Chemistries granted FDA emergency use authorization

Inconsistent SARS-CoV-2 antibody results in nephrology workers

Inconsistent SARS-CoV-2 antibody results in nephrology workers

UArizona aims to develop a device for quick and accurate detection of pathogens, biological threats

UArizona aims to develop a device for quick and accurate detection of pathogens, biological threats

SphingoTec launches point-of-care test for bio-ADM, a biomarker for life threatening endothelial dysfunction

SphingoTec launches point-of-care test for bio-ADM, a biomarker for life threatening endothelial dysfunction

SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of bio-ADM

SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of bio-ADM

New assay improves detection of SARS-CoV-2 antibodies

New assay improves detection of SARS-CoV-2 antibodies

Study finds significant variability in the accuracy of currently available COVID-19 antibody tests

Study finds significant variability in the accuracy of currently available COVID-19 antibody tests

New technology allows quick and cost-effective identification of cancer biomarkers

New technology allows quick and cost-effective identification of cancer biomarkers

Novel antibody test for SARS-CoV-2

Novel antibody test for SARS-CoV-2

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Novel biomarkers required to triage and monitor severely ill COVID-19 patients

Novel biomarkers required to triage and monitor severely ill COVID-19 patients

Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies

Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies

Siemens receives FDA approval for SARS-CoV-2 antibody test

Siemens receives FDA approval for SARS-CoV-2 antibody test

Research provides new evidence for potential blood-based biomarker for Alzheimer's

Research provides new evidence for potential blood-based biomarker for Alzheimer's

Portable analyzer rapidly detects anti-virus antibody in blood serum

Portable analyzer rapidly detects anti-virus antibody in blood serum

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Nanosized silver cubes can make it easier to read diagnostic tests

Nanosized silver cubes can make it easier to read diagnostic tests

Using Multiplex Assays to Discover Biomarkers for Parkinson’s Disease

Using Multiplex Assays to Discover Biomarkers for Parkinson’s Disease

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix